ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

EU GACP-Compliant Pharmaceutical Lab Design & Cultivation Consulting Update

Hempire Labs S.L. has announced updates to its lab design consulting services for the pharmaceutical cannabis industry.

-- Following the updates, producers of medicinal cannabis can turn to the company for guidance on facility design, processes, automation, and cleanroom engineering solutions. Hempire Labs S.L. specializes in helping both startups and established businesses optimize their operations via industry-specific strategies and lab innovations.

More details can be found at https://hempirelabs.eu

The consultancy brings expertise in handling regulatory guidelines for the production of pharmaceutical cannabis. In particular, Hempire Labs helps clients ensure that their operations comply with Good Manufacturing Practice (GMP), Good Distribution Practice (GDP), and Good Agricultural and Collection Practice (GACP) standards within the EU to improve the quality and safety of their products.

Hempire Labs has observed that health providers across the globe are waking up to the potential of herbal interventions.

“The science of medical cannabis is an evolving field, with ongoing research uncovering new therapeutic potentials and refining our understanding of how cannabinoids interact with the human body,” a spokesperson says.

According to Statista, the medicinal cannabis market in Europe is predicted to reach a market value of around $2 billion by 2027, driven by widespread efforts to expand legalization and develop therapeutic applications. The sector's growth to date is grounded in improvements to manufacturing processes, cultivation techniques, and increasingly sophisticated extraction methods, which have attracted significant investment across the globe.

Hempire Labs founder Mardi Joubanian has dedicated his career to setting up and developing high-quality lab facilities with a focus on advanced purification and extraction protocols. His expertise is complemented by co-founder Paulina Molyneux-Webb, an accomplished educator, herbalist, and project manager who keeps the company on track with the latest developments and innovations in the industry.

Hempire clients can seek advice on what equipment will be most suitable for their facility. This includes options such as Supercritical Fluid CO2 extraction machines, which nurture purer and more potent products without compromising the natural profile of the cannabis plant or the size of the yield.

Interested parties can book a consultation with the Hempire Labs team for a €125.00 fee.

For more information, go to https://hempirelabs.eu

Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: POLIGONO NUEVA CAMPANA, 93 NAVE, Marbella, Andalucía 29660, Spain
Website: https://hempirelabs.eu

Source: NewsNetwork

Release ID: 89162534

In case of identifying any errors, concerns, or inconsistencies within the content shared in this press release that necessitate action or if you require assistance with a press release takedown, we strongly urge you to notify us promptly by contacting error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our expert team is committed to addressing your concerns within 8 hours by taking necessary actions diligently to rectify any identified issues or supporting you with the removal process. Delivering accurate and reliable information remains our top priority.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.